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Synthesis of Poly-Aib Oligopeptides and Aib-Containing
Peptides via the 'Azirine/Oxazolone Method', and their
crystal structures
Abstract
The protected poly-Aib oligopeptides Z-(Aib)n-N(Me)Ph with n = 2 - 6 were prepared
according to the 'azirine/oxazolone method', i.e., by coupling amino or peptide acids with
2,2,N-trimethyl-N-phenyl-2H-azirin-3-amine (1a) as an Aib synthon (Scheme 2). Following the
same concept, the segments Z-(Aib)3-OH (9) and H-L-Pro-(Aib)3-N(Me)Ph (20) were
synthesized, and their subsequent coupling with N,N'-dicyclohexylcarbodiimide (DCC)/ZnCl2
led to the protected heptapeptide Z-(Aib)3-L-Pro-(Aib)3-N(Me)Ph (21; Scheme 3). The crystal
structures of the poly-Aib oligopeptide amides were established by X-ray crystallography
confirming the 310-helical conformation of Aib peptides.
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1) Part of the PhD thesis of I.D.-D., University of Zürich, 1995.  
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The protected poly-Aib oligopeptides Z-(Aib)n-N(Me)Ph with n = 2 – 6 were prepared 
according to the ‘azirine/oxazolone method’, i.e., by coupling of amino or peptide acids with 
2,2,N-trimethyl-N-phenyl-2H-azirin-3-amine (1a) as an Aib synthon (Scheme 2). Following 
the same concept, the segments Z-(Aib)3-OH (9) and H-L-Pro-(Aib)3-N(Me)Ph (20) were 
synthesized, and their subsequent coupling with DCC/ZnCl2 led to the protected heptapeptide 
Z-(Aib)3-L-Pro-(Aib)3-N(Me)Ph (21, Scheme 3). The crystal structures of the poly-Aib 
oligopeptide amides were established by X-ray crystallography confirming the 310-helical 
conformation of Aib peptides. 
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1. Introduction. – The broad interest in Aib-containing oligopeptides is well 
documented [1], and a large number of recent articles show that this type of peptides still 
attract attention because of their structural (e.g. [2]) and antimicrobial properties (e.g. [3]). In 
the last twenty years, we have shown that N,N-disubstituted 2,2-dimethyl-2H-azirin-3-amines 
1 are useful building blocks for 2-aminoisobutyric acid (Aib) in the syntheses of heterocycles 
and peptides [4]. The so-called ‘azirine/oxazolone method’ proved to be a convenient 
synthetic approach for the introduction of Aib into peptides [5] (Scheme 1). After the coupling 
of an amino acid or peptide acid with 1, the resulting dipeptide amide 2 was hydrolyzed 
selectively to give the dipeptide acid 3. Subsequent coupling with an amino acid ester by 
using DCC/ZnCl2 led, via the intermediate 1,3-oxazol-5(4H)-one 4, to the tripeptide 5. This 
method has been used successfully in the syntheses of model peptides and naturally occurring 
peptaibols2), e.g., segments of alamethicin [8] and zervamicin II-2 [9], derivatives of 
trichovirin I 1B [10] and trichotoxin A-50(G) [11], as well as hypomurocin A1 [12]. 
Recently, the ‘azirine/oxazolone method’ has been adopted for solid phase synthesis 
[13]. 
 
Scheme 1 
 
The repetition of the reaction sequence of azirine coupling and selective hydrolysis of 
the C-terminal amide group allows the direct coupling of Aib segments with a peptide chain. 
This convenient and efficient approach has been used for the preparation of peptides like HO–
                                                 
2)  The term ‘peptaibol’ is used for amphiphilic, membrane-active Aib-containing peptides 
with an acylated N-terminus and a C-terminal amino alcohol, which show antibiotic 
properties [6][7]. 
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CHR1–CO–(NH–CMe2–CO)n–N(Me)R2 [14] and Z–NH–CHR1–CO–(NH–CMe2–CO)n–
N(Me)R2 [15] as precursors of cyclic depsipeptides and peptides, respectively. 
The goal of the present study was to demonstrate the usefulness of 2,2-dimethyl-2H-
azirin-3-amines for the preparation of poly-Aib peptides and the determination of the 
conformation of these oligopeptides in the crystalline state. 
 
2. Results and Discussion. – 2.1. Synthesis of Poly-Aib-Oligopeptides. The synthesis 
of the poly-Aib-oligopeptides was carried out in analogy to the preparations of the linear 
peptides of type X–CHR1–CO–(NH–CMe2–CO)n–N(Me)R2 mentioned above [14][15]. The 
Z-protected 2-aminoisobutyric acid (Z-Aib-OH) [16], which had been prepared in 95% yield 
by treatment of Aib with benzyl chloroformate in a mixture of 2N aqueous NaOH and 
dioxane, was dissolved in Et2O and reacted with 1.1 equiv. 2,2,N-trimethyl-N-phenyl-2H-
azirin-3-amine (1a) at room temperature to give Z-Aib-Aib-N(Me)Ph (6a) in quantitative 
yield (Scheme 2). The dipeptide amide crystallized directly from the mixture and was isolated 
by filtration. Selective hydrolysis of the terminal amide group was achieved in THF/6N HCl 
(1:1) at room temperature and led to the dipeptide acid Z-Aib-Aib-OH (7) in 94% yield. 
 
Scheme 2 
 
The reaction sequence of azirine coupling and hydrolysis was repeated with 7 and 
subsequently three times in addition. A suitable solvent for the coupling step with 7 was THF; 
in the cases of the higher homologues 9, 11, and 13, DMF was used. To obtain a clear 
solution, the mixtures in DMF were heated to 40–70° and then cooled to 0°. After addition of 
1a, the solution was allowed to warm to room temperature. The peptide amides 8a and 12 
crystallized directly from the mixture, whereas 10 and 14 were obtained as yellow oils, but 
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crystallized after treatment with Et2O/petroleum ether and Et2O, respectively. The pure 
peptide amides were isolated in 85–100% yield. The selective hydrolysis of 8a and 10 
occurred smoothly at room temperature to give the peptide acids 9 and 11 in 85 and 98% 
yield, respectively. In the case of the rather insoluble 12, the hydrolysis was carried out at 60° 
and gave 13 in 98% yield. 
2.2. Synthesis of the Heptapeptide Z-(Aib)3-Pro-(Aib)3-N(Me)Ph  (21). The protected 
heptapeptide amide 21 was synthesized via a combination of the azirine coupling/hydrolysis 
described above and the segment condensation via a 1,3-oxazol-5(4H)-one (Scheme 3), i.e. 
with the ‘azirine/oxazolone method’. The first segment Z-(Aib)3-OH (9) was prepared 
analogously to Scheme 2, but by using 2,2,N,N,tetramethyl-2H-azirin-3-amine (1b) as the Aib 
synthon. The azirine coupling gave 6b and 8b in 87 and 92% yield, respectively, and the 
selective hydrolysis to 7 and 9 was almost quantitative. The second segment, Z-L-Pro-(Aib)3-
N(Me)Ph (19) was obtained in a total yield of 51% by repeated coupling of Z-L-Pro-OH with 
1a, followed by the selective hydrolysis. The reason for the choice of 1a was the faster 
hydrolysis of the N-methyl-N-phenylamides in 6N HCl/THF in comparison with that of the 
corresponding N,N-dimethylamides. Therefore, the racemization of Pro as well as the acid-
catalyzed cleavage of Pro-Aib [5b][17] was minimized. The hydrolysis of 15 and 17 were 
complete already after 3 and 3.5 h, respectively, and afforded the products in 80 and 94% 
yield. 
 
Scheme 3 
 
Finally, the Z-protecting group of the tetrapeptide 19 was removed by hydrogenolysis 
with Pd/C yielding 20, and the segments 9 and 20 were condensed by using the coupling 
reagent DCC/ZnCl2 [5a] to give 21 in 75% yield. 
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2.3. Crystal Structures of the Poly-Aib-Oligopeptide Amides. Nowadays it is well 
known that the preferred conformation of peptides containing Aib (and some other α,α-
dialkylated glycines) is the 310-helix, which is a sequence of β-turns of type III or III’, in 
which the ideal values for all torsion angles φ (CO–N–Cα–CO) and ψ (N–Cα–CO–N) are ± 
60° and ± 30°, respectively. The negative values stand for the right-handed helix (β-turns of 
type III) and the positive ones for the left-handed helix (β-turns of type III’). An additional 
characteristic feature consists of the intramolecular H-bonds between CO of amino acid i and 
NH of amino acid i+4, which form 10-membered rings, and thereby stabilize the helical 
structure. 
A rather large series of poly-Aib-oligopeptide derivatives have been prepared and their 
structures analyzed (see e.g. [16][18]). In most cases, peptide esters were investigated. The 
crystal structures of the present set of Z-(Aib)n-N(Me)Ph (n = 3 – 6)3), i.e. poly-Aib amides, 
are in good agreement with the 310-helical structures of analogous derivatives: the average 
magnitudes of φi and ψi are 55.3° and 31.5°, i.e. they correspond well with the typical values 
of ± 60° and ± 30° (see, e.g. [16b][18b,e,f]). 
Z-(Aib)2-N(Me)Ph (6a). The molecular structure of 6a in the crystal is shown in Fig. 1. 
The torsion angles ω of the amide groups are in the allowed region for trans-amide bonds 
(Table 1). The values of the torsion angle-pair φ/ψ for Aib(2) are + 55.2(3)° and + 41.9(3)°, 
i.e., compatible with a left-handed 310-helix, but the corresponding ψ-value for Aib(1) is far 
from the allowed values. Note that since the space group is centrosymmetric, the crystal also 
contains the equal number of molecules existing in a right-handed helix. 
 
                                                 
3)  The dipeptide derivative Z-(Aib)2-N(Me)Ph (6a) is not able to form a β-turn and, 
therefore, is not included in this comparison. 
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Fig. 1. ORTEP Plots [19] of the molecular structures of a) 6a and b) one of the two 
symmetry-independent molecules of  8a (50% probability ellipsoids, arbitrary numbering of 
the atoms) 
 
The molecule 6a does not form intramolecular H-bonds. Each N–H group of the 
molecule acts as a donor for intermolecular H-bonds:  N(2)–H forms an intermolecular H-
bond with the amide O(1)-atom at the Ph(Me)N end of a neighboring peptide molecule and 
thereby links the molecules into extended chains which run parallel to the [010] direction and 
which can be described by a graph set motif [20] of C(5).  N(3)–H forms an intermolecular H-
bond with the amide O(2)-atom in the middle of a different neighboring peptide molecule and 
thereby links the molecules into centrosymmetric dimers, in which the interactions can be 
described by a graph set motif of R2,2(10). The combination of these interactions links the 
molecules into two-dimensional networks which lie parallel to the (1 0 -1) plane. 
 
Table 1. Torsion Angles ω, φ, and ψ of the Backbone of Compounds 6a, 8a, 10, 12, 
and 14 in the Crystal (atom numbering refers to Figs. 1 – 3) 
 
Z-(Aib)3-N(Me)Ph (8a). There are two molecules with almost identical conformations 
but with opposite helicity in the asymmetric unit. As the space group is centrosymmetric, both 
of the independent molecules exist in the crystal in their left- and right-handed forms. A view 
of molecule A is shown in Fig. 1. Both molecules form a β-turn, stabilized by an 
intramolecular H-bond between N(2)–H of Aib(2) and C=O(4) of the Z-protecting group 
(Table 2). This corresponds with the observation of Toniolo et al. that polypeptides with a Z-
protected N-terminal Aib form a β-turn of type III with a 4 → 1 H-bond between NH of the 
third amino acid and C=O of the Z-group [21]. All torsion angles ω of the amide groups show 
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characteristic values for trans-amide bonds (Table 1). The average magnitudes of the torsion 
angle-pairs φ1–3/ψ1–2 are 57.3° and 33.8°, typical for a 310-helix. The torsion angles ψ3A and 
ψ3B of the C-terminal Aib differ significantly from the ideal value of ± 30°, a fact that has also 
been described earlier [21a]. 
Each N–H group of each independent molecule acts as a donor for H-bonds.  In 
molecule A, N(2)–H forms an intramolecular H-bond with the urethane O(4)-atom that is 
seven atoms along the peptide backbone.  This interaction has a graph set motif [20] of S(10) 
and serves to maintain a fairly rigid helical conformation of the peptide.  N(3)–H and N(4)–H, 
which are unable to form an intramolecular interaction because of their positions in the 
backbone, form intermolecular H-bonds with the amide O(31’) and O(32’)-atoms closest to 
the Ph(Me)N end of the same neighboring B molecule.  Molecule B exhibits an identical 
pattern of H-bonds.  Each of these specific donors links molecules A and B alternately into 
extended chains which run parallel to the [101] direction, and which can be described by a 
graph set motif of C2,2(16).  The double-bridge between adjacent molecules resulting from 
both the interactions forms a ring with a graph set motif of R2,2(12). 
 
Table 2. Intramolecular H-bonds in 8a, 10, 12, and 14 in the Crystal (atom numbering 
refers to Figs. 1 – 3) 
 
Z-(Aib)4-N(Me)Ph (10). The asymmetric unit of the centrosymmetric structure 
contains one molecule of the peptide 10 and one molecule of H2O. A view of the molecule is 
shown in Fig. 2. The right-handed 310-helical conformation of the reference molecule is 
stabilized by two intramolecular 4 → 1 H-bonds, which form β-turns of type III’ (N(2)–
H….O(4), N(3)–H….O(5)). As in the previous case, N(3)–H forms a H-bond with the C=O(5) 
group of the urethane. All torsion angles ω are in the region of trans amide bonds, and the 
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magnitudes of the torsion angles φ1–4 and ψ1–3 are those of a 310-helical conformation (Table 
1; average values –55.3° and –29.0°, resp.). Again, the value of ψ4 deviates significantly from 
± 30°. It is worth mentioning that φ4 and ψ4 are positive whereas φ1–3 and ψ1–3 are all 
negative, i.e. the helicity of the last Aib is inverted. 
 
Fig. 2. ORTEP Plots [19] of the molecular structures of a) 10 and b) 12 (50% 
probability ellipsoids, arbitrary numbering of the atoms, H2O molecule in 10 omitted) 
 
Each N–H group of the molecule 10 acts as a donor for H-bonds.  N(2)–H and N(3)–H 
form intramolecular H-bonds with the amide O(4) and O(5)-atoms that are seven atoms along 
the peptide backbone.  Each of these interactions has a graph set motif [20] of S(10). N(5)–H, 
which is unable to form an intramolecular interaction because of its position in the backbone, 
forms an intermolecular H-bond with the amide O(1’)-atom at the Ph(Me)N end of a 
neighboring peptide molecule.  These interactions link the molecules into extended chains 
which run parallel to the [010] direction and which can be described by a graph set motif of 
C(14).  N(4)–H forms an intermolecular H-bond with the O-atom of the H2O molecule, 
which, in turn, donates a H-bond to the amide O(1’)-atom at the Ph(Me)N end of the next 
peptide molecule in the chain.  These interactions can be described by a binary graph set motif 
of C2,2(13). 
Z-(Aib)5-N(Me)Ph (12). The molecular structure is shown in Fig. 2. The reference 
molecule in the asymmetric unit of the centrosymmetric structure forms a left-handed 310-
helix, stabilized by three intramolecular H-bonds of type 4 → 1, i.e. three β-turns of type III: 
N(2)–H….O(4), N(3)–H….O(5), and N(4)–H….O(6), the last one including the C=O of the 
urethane (Table 2). The torsion angles ω are typical for trans amide bonds, and the 
magnitudes of the torsion angles φ1–4 and ψ1–4 are characteristic for a 310-helical conformation 
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(Table 1; average values +56.3° and +28.5°, resp.). The values of the last pair φ5 and ψ5 are 
quite different and have the opposite sign (–47.6(6)° and –54.1(5)°) compared with φ1–4 and 
ψ1–4. 
Each N–H group of the molecule acts as a donor for H-bonds.  N(2)–H, N(3)–H, and 
N(4)–H form intramolecular H-bonds with the amide O(4), O(5), and O(6)-atoms that are 
seven atoms along the peptide backbone.  Each of these interactions has a graph set motif [20] 
of S(10).  These H-bonds stabilize the peptide in a fairly rigid helical conformation.  N(5)–H 
and N(6)–H, which are unable to form an intramolecular interaction because of their positions 
in the backbone, form intermolecular H-bonds with the amide O(1’) and O(2’)-atoms closest 
to the Ph(Me)N end of the same neighboring molecule.  Each of these specific donors links 
the molecules into extended chains which run parallel to the [100] direction and which can be 
described by a graph set motif of C(14).  The double-bridge between adjacent molecules 
resulting from both the interactions forms a ring with a graph set motif of R2,2(12). 
Z-(Aib)6-N(Me)Ph (14). The molecular structure is shown in Fig. 3. The asymmetric 
unit contains one molecule of 14 plus a site, which is approximately 25% occupied by a H2O 
molecule. Four intramolecular H-bonds of type 4 → 1, i.e. four β-turns of type III’ (N(2)–
H….O(4), N(3)–H….O(5), N(4)–H….O(6), and N(5)–H….O(7), Table 2), stabilize a right-
handed 310-helix. The compound crystallizes in a chiral space group, so all molecules 
exclusively posses a right-handed helix. As in the cases of 8a, 10, and 12, the acceptor of the 
last H-bond is the C=O group of the urethane. All torsion angles ω are compatible with trans 
amide bonds, and the values of the torsion angles φ1–5 and ψ1–5 are characteristic for a 310-
helical conformation (Table 1; average values –54.6° and –35.1°, resp.). Again, the values of 
the last pair φ6 and ψ6 differ and have the opposite sign (+49.3(4)° and +52.7(4)°). 
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Fig. 3. ORTEP Plot [19] of the molecular structure of 14 (50% probability ellipsoids, 
arbitrary numbering of the atoms, the H2O molecule has been omitted) 
 
Each N–H group of the molecule acts as a donor for H-bonds.  The four interactions 
involving N(2)–H, N(3)–H, N(4)–H, and N(5)–H are intramolecular H-bonds with the amide 
O(4), O(5), O(6), and O(7)-atoms that are seven atoms along the peptide backbone.  Each of 
these interactions has a graph set motif [20] of S(10).  This serves to maintain a fairly rigid 
helical conformation of the peptide.  N(7)–H, which is unable to form an intramolecular 
interaction because of its position in the backbone, forms an intermolecular H-bond with the 
amide O-atom at the Ph(Me)N end of a neighboring peptide molecule.  These interactions link 
the molecules into extended chains which run parallel to the [001] direction and which can be 
described by a graph set motif of C(20).  N(6)–H forms an intermolecular H-bond with the O-
atom of the H2O molecule, which, in turn, donates a H-bond to the first amide O-atom in the 
next peptide molecule in the chain.  These interactions can be described by a binary graph set 
motif of C2,2(19). 
 
3. Conclusions. – With the presented syntheses of poly-AIB-oligopeptides and an 
Aib-containing heptapeptide, the usefulness of 2,2-dimethyl-2H-azirin-3-amines as Aib 
synthons in peptide synthesis was proved. Repeated azirine coupling with Z-protected α-
aminoisobutyric acid (Aib) allowed the smooth and efficient preparation of the Aib-oligomers 
(Z-(Aib)2–6-N(Me)Ph) with a C-terminal amide function. The X-ray crystal-structure analyses 
of these oligomers confirmed the high preference of β-turns and the 310-helical conformation. 
It is worth mentioning that the dimer Z-Aib-Aib-N(Me)Ph is not able to form a β-turn with 
the corresponding 4 → 1 H-bond because it is to short, but the values of the torsion angles of 
Aib(2) are close to those of an Aib involved in a β-turn. As expected, in all oligomers the 
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terminal amide group is not involved in intramolecular H-bonding and, therefore, does not 
influence the structure of the peptide backbone significantly (cf. [18]). Furthermore, the 
conformation of the Z-protecting group, which is involved in a 4 → 1 H-bond stabilizing the 
first β-turn, is similar for all investigated oligopeptides and shows the trans,trans-
conformation (cf. [21b]). The torsion angles ω of the peptide bonds of the studied Aib-
oligomers are typically in the range of 171 – 180° (trans amide bonds), and only in the two 
crystallographically independent molecules of Z-(Aib)3-N(Me)Ph were values of ca. 164° 
observed for ω2.  
With the synthesis of Z-(Aib)3-Pro-(Aib)3-N(Me)Ph it was demonstrated once more 
that the combination of azirine coupling, selective hydrolysis, and coupling of a peptide 
segment via an 5(4H)-oxazolone, i.e. the ‘azirine/oxazolone method’, is very suitable for the 
synthesis of Aib-rich oligopeptides. 
 
We thank the analytical units of our institute for spectra and analyses. Financial 
support of the work by the Stipendienfonds der Basler Chemischen Industrie (I. D.-D.), the 
Swiss National Science Foundation, and F. Hoffmann-La Roche AG, Basel, is gratefully 
acknowledged. Dr. B. R. Vincent is thanked for the crystallographic data collection and the 
initial solution and refinement of the structures. 
 
 
Experimental Part 
 
1. General. Solvents were purified by standard procedures; THF was distilled from 
Na/benzophenone, Et2O from Na, and CH2Cl2 from CaCl2; DMF, puriss. was dried over 
molecular sieves. All commercially available chemicals were of analytical grade and were 
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used without purification. The 2H-azirin-3-amines 1a and 1b were prepared according to the 
references cited in [4]. TLC: aluminium sheets, silica gel 60 F254 (Merck). Prep. TLC: glass 
plates, silica gel 60 F254 (2 mm; Merck). Column chromatography (CC, flash chromatography 
[22]): silica gel Merck 60 (0.040–0.063 mm). High performance liquid chromatography 
(HPLC) with a Varian 2510 instrument and Varian 2550 UV detector (254 nm) or Waters 600 
E instrument with Waters 484 UV detector (254 nm); Lichrosorb RP 18 or LichroCast RP 18 
(reversed phase) columns. M.p.: Mettler-FP-5 apparatus; uncorrected.  IR Spectra: Perkin-
Elmer-297 or 781 spectrophotometer; in KBr, in cm–1. 1H- and 13C-NMR Spectra: Varian 
XL-200 or Bruker-AM-400 instrument (200 and 50.4 MHz, or 400 and 100.7 MHz, resp.); δ 
in ppm, coupling constants J in Hz; multiplicity of C-atoms from DEPT spectra. MS: 
Finnigan MAT-90 (EI) or Finnigan SSQ-700 (CI with NH3) instrument. Elemental analyses 
were performed at the Institute of Organic Chemistry of the University of Zürich.  
Abbreviations: AcOEt = ethyl acetate, Aib = 2-aminoisobutyric acid, Bn = benzyl, 
DCC = N,N’-dicyclohexyl carbodiimide, Z = benzyloxycarbonyl. 
General Procedure 1 (GP 1, azirine coupling). To a 0.5M soln. of the peptide acid in 
Et2O, THF, or DMF at 0° was added azirine 1a or 1b (1.1 equiv.) dropwise, and the mixture 
was stirred at 0° for 10 min and at r.t. for several h. The precipitated product was filtered and 
washed with Et2O and petroleum ether. The solvent of the mother liquor was evaporated and 
the oily residue crystallized by treatment with petroleum ether at 0°. The combined crystals 
were dried in h.v. 
General Procedure 2 (GP 2, selective hydrolysis). A 0.1M soln. of the peptide amide in 
THF/6N HCl (1:1) was stirred at r.t. or at 60° and the progress of the reaction followed by 
TLC. When the reaction was complete,  the same volume of 2N HCl was added, the product 
was extracted with Et2O, and the combined org. phase was dried (Na2SO4). After evaporation 
of the solvent, the product was dried in h.v. 
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2. Synthesis of Poly-Aib-Oligopeptides. 2.1. N-Benzyloxycarbonyl-2-methylalanine (Z-
Aib-OH) [16]. To a vigorously stirred soln. of Aib (20 g, 194 mmol) in 2N HCl/dioxane (2:1, 
145.5 ml) at 0° were added simultaneously a soln. of benzyl chloroformate (79.4 g, 466 
mmol) in toluene and 4N NaOH (37 ml) to keep the pH basic. Then, the mixture was warmed 
to r.t., and stirring was continued overnight. After addition of Et2O, the org. phase was 
separated, and 6N HCl was added to the cooled aq. phase, which was then extracted with Et2O 
(3×). The combined org. phase was evaporated, and the oily residue was crystallized by 
addition of petroleum ether at reflux temperature and subsequent cooling to r.t. The crystalline 
solid was washed with petroleum ether and dried in h.v. Yield of Z-Aib-OH: 44.5 g (95%). 
M.p. 75.5°. 1H-NMR (90 MHz, CDCl3): 10.65 – 10.35 (br. s, COOH); 7.35 (s, 5 arom. H); 
5.65 – 5.25 (br. s, NH); 1.60 (s, Me2C). 
2.2. N-Benzyloxycarbonyl-2-methylalanyl-2-methyalanine-N-methyl-N-phenylamide 
(Z-(Aib)2-N(Me)Ph, 6a). According to GP 1, to a soln. of Z-Aib-OH (1.30 g, 5.5 mmol) in 
Et2O (10 ml), azirine 1a (1.0 g, 6.0 mmol) was added. After 5 min, a precipitate formed. The 
mixture was kept at 4° overnight and then filtered. Yield of 6a: 2.28 g (quant.). Colorless 
solid. M.p. 152 – 154°. IR (CHCl3): 3430w, 3370w, 2940w, 1725m, 1670m, 1630m, 1595w, 
1495s, 1455m, 1390w, 1365w, 1170w, 1120w, 1090w, 1075w, 705w. 1H-NMR (200 MHz, 
CDCl3): 7.48 (br. s, NH); 7.42 – 7.30, 7.30 – 7.20 (2m, 10 arom. H); 5.36 (br. s, NH 
urethane); 5.07 (s, PhCH2O); 3.28 (s, MeN); 1.47, 1.42 (2s, 2 Me2C). 13C-NMR (50 MHz, 
CDCl3): 173.6, 172.7 (2s, 2 CO(amide)); 154.9 (s, CO(urethane)); 144.3, 136.5 (2s, 2 arom. 
C); 129.3, 128.4, 128.3, 128.03, 128.0, 127.9 (6d, 10 arom. CH); 66.4 (t, PhCH2O); 58.4, 57.0 
(2s, 2 Me2C); 41.5 (q, MeN); 25.2, 25.1 (2q, 2 Me2C). Anal. calc. for C23H29N3O4 (411.51): C 
67.13, H 7.10, N 10.21; found: C 67.25, H 7.03, N 10.30. 
Suitable crystals for the X-ray crystal-structure determination were grown from 
DMSO/H2O by slow evaporation of the solvent. 
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2.3. N-Benzyloxycarbonyl-2-methylalanyl-2-methyalanine (Z-(Aib)2-OH, 7). 
According to GP 2, 6a (3.74 g, 9.1 mmol) was hydrolysed. After evaporation of Et2O, 7 was 
obtained as a colorless, crystalline solid. Yield: 2.75 g (94%). M.p. 154 – 158°. IR (KBr): 
3430m, 3300m, 3040w, 2990w, 2950w, 1725s, 1705s, 1655s, 1535s, 1510m, 1470w, 1460w, 
1445w, 1420w, 1380w, 1360w, 1300w, 1255m, 1230m, 1210w, 1185w, 1170w, 1080m, 970w, 
855w, 785w, 750w, 700w. 1H-NMR (200 MHz, (D6)DMSO): 12.27 – 12.20 (br. s, COOH); 
7.48 (s, NH); 7.37 – 7.26 (m, 5 arom. H, NH); 5.02 (s, PhCH2O); 1.33 (s, 2 Me2C). 13C-NMR 
(50 MHz, (D6)DMSO): 175.8 (s, COOH); 173.4 (s, CO(amide)); 154.7 (s, CO(urethane)); 
137.2 (s, arom. C); 128.3, 127.7, 127.5 (3d, 5 arom. CH); 65.0 (t, PhCH2O); 56.0, 55.1 (2s, 2 
Me2C); 25.0, 24.4 (2q, 2 Me2C). CI-MS: 323 (100, [M+1]+). Anal. calc. for C16H22N2O5 
(322.36): C 59.62, H 6.88, N 8.69; found: C 59.54, H 6.82, N 8.49. 
2.4. N-Benzyloxycarbonyl-2-methylalanyl-2-methylalanyl-2-methyalanine-N-methyl-
N-phenylamide (Z-(Aib)3-N(Me)Ph, 8a). According to GP 1, to a soln. of 7 (2.0 g, 6.2 mmol) 
in THF (14 ml) was added 1a (1.14 g, 6.5 mmol). After warming to r.t., a precipitate formed. 
The mixture was stirred at r.t. for 4 h and kept at 4° overnight. Yield of 8a: 2.95 g (95%). 
Colorless solid. M.p. 177 – 178°. IR (KBr): 3340m, 3290m, 3040w, 2990w, 2940w, 1710m, 
1690m, 1660s, 1635s, 1595w, 1540m, 1515m, 1495m, 1465m, 1270m, 1225w, 1205w, 1170w, 
1100m, 1090m, 915w, 740w, 710w. 1H-NMR (200 MHz, (D6)DMSO): 7.75, 7.66 (2s, 2 NH); 
7.40 – 7.15 (m, 10 arom. H, NH); 5.11 (s, PhCH2O); 3.16 (s, MeN); 1.31, 1.30, 1.29 (3s, 3 
Me2C). 13C-NMR (50 MHz, (D6)DMSO): 173.7, 173.1, 172.4 (3s, 3 CO(amide)); 155.5 (s, 
CO(urethane)); 146.0, 137.2 (2s, 2 arom. C); 128.6, 128.3, 127.6, 126.9, 126.8, 125.9 (6d, 10 
arom. CH); 65.1 (t, PhCH2O); 56.2, 56.1, 55.9 (3s, 3 Me2C); 39.1 (q, MeN); 25.4, 24.8, 24.7 
(3q, 3 Me2C). Anal. calc. for C27H36N4O5 (496.61): C 65.30, H 7.31, N 11.28; found: C 65.52, 
H 7.54, N 11.05. 
Suitable crystals for the X-ray crystal-structure determination were grown from 
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DMSO/H2O by slow evaporation of the solvent. 
2.5. N-Benzyloxycarbonyl-2-methylalanyl-2-methylalanyl-2-methyalanine (Z-(Aib)3-
OH, 9). According to GP 2, 8a (4.95 g, 10.0 mmol) was hydrolyzed. After 2 h, the precipitate 
was filtered. The aq. phase was extracted with Et2O, the org. phase was dried (Na2SO4), then 
Et2O was evaporated, the combined solid material was washed wit Et2O and dried in h.v. 
Yield of 9: 3.43 g (85%). Colorless solid. M.p. 195 – 196°. IR (KBr): 3470m, 3410m, 3320m, 
3300s, 3080w, 3020w, 2990w, 2930w, 1730s, 1700s, 1660s, 1635s, 1550m, 1535s, 1470w, 
1455m, 1390m, 1345m, 1310m, 1275s, 1225w, 1210w, 1180m, 1100s, 1080w, 740m. 1H-NMR 
(200 MHz, (D6)DMSO): 7.62 (br. s, 2 NH); 7.39 – 7.31 (m, 5 arom. H, NH); 5.07 (s, 
PhCH2O); 1.30 (br. s, 3 Me2C). 13C-NMR (50 MHz, (D6)DMSO): 175.5 (s, COOH); 173.4, 
173.2 (2s, 2 CO(amide)); 155.4 (s, CO(urethane)); 137.0 (s, arom. C); 128.3, 127.8, 127.6 (3d, 
5 arom. CH); 65.3 (t, PhCH2O); 56.2, 55.7, 54.8 (3s, 3 Me2C); 24.9, 24.5 (2q, 3 Me2C). CI-
MS: 408 (100, [M+1]+). Anal. calc. for C20H29N3O6 (407.47): C 58.95, H 7.17, N 10.31; 
found: C 58.87, H 7.33, N 10.55. 
2.6. N-Benzyloxycarbonyl-2-methylalanyl-2-methylalanyl-2-methylalanyl-2-
methyalanine-N-methyl-N-phenylamide (Z-(Aib)4-N(Me)Ph, 10). At ca. 40°, 9 (3.20 g, 7.85 
mmol) was dissolved in DMF (17 ml). After cooling to 0°, according to GP 1, 1a (1.55 g, 8.2 
mmol) was added and the mixture stirred at r.t. for 4 h.  The solvent was evaporated and the 
yellow oily residue was treated with Et2O. The formed solid was filtered, dissolved in DMF, 
precipitated by addition of Et2O (3×), and dried in h.v. Yield of 10: 4.24 g (93%). Colorless 
solid. M.p. 194 – 195°. IR (KBr): 3420w, 3330m, 3300m, 3030w, 2990w, 2940w, 1705s, 1680 
– 1650s (br), 1630m, 1595m, 1530s, 1495m, 1470m, 1455m, 1395m, 1380m, 1365m, 1270m, 
1220w, 1170w, 1090m, 710m. 1H-NMR (200 MHz, (D6)DMSO): 8.21, 7.84, 7.55 (3 br. s, 3 
NH); 7.38 – 7.16 (m, 10 arom. H, NH); 5.08 (s, PhCH2O); 3.28 (s, MeN); 1.42, 1.34, 1.28, 
1.26 (4s, 4 Me2C). 13C-NMR (50 MHz, (D6)DMSO): 175.1, 173.9, 173.1, 172.7 (4s, 4 
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CO(amide)); 155.7 (s, CO(urethane)); 146.2, 137.5 (2s, 2 arom. C); 128.6, 128.3, 127.7, 
127.2, 126.8, 125.8 (6d, 10 arom. CH); 65.5 (t, PhCH2O); 56.04, 56.0 (2s, 4 Me2C); 39.1 (q, 
MeN); 25.5, 25.1, 24.6 (3q, 4 Me2C). Anal. calc. for C31H43N5O6 (581.72): C 64.01, H 7.45, N 
12.04; found: C 64.15, H 7.48, N 12.02. 
Suitable crystals for the X-ray crystal-structure determination were grown from 
DMSO/H2O by slow evaporation of the solvent. 
2.7. N-Benzyloxycarbonyl-2-methylalanyl-2-methylalanyl-2-methylalanlyl-2-
methyalanine (Z-(Aib)4-OH, 11). According to GP 2, 10 (8.81 g, 15.1 mmol) was hydrolyzed 
in THF/6N HCl (152 ml). After 2.5 h, 2N HCl (150 ml) was added and the precipitate was 
filtered. The solid material was washed with CH2Cl2 and dried in h.v. Yield of 11: 7.31 g 
(98%). Colorless solid. M.p. 232 – 233°. IR (KBr): 3370w, 3300m, 3070w, 3000w, 1730m, 
1710s, 1660s, 1545m, 1530m, 1515m, 1455w, 1400w, 1390w, 1365w, 1300w, 1280w, 1260m, 
1230w, 1170w, 1080m, 955w, 810w, 790w, 700w. 1H-NMR (200 MHz, (D6)DMSO): 11.83 
(br. s, COOH); 8.07, 7.78 (2s, 2 NH); 7.41 – 7.25 (m, 5 arom. H, NH); 7.18 (s, NH); 5.09 (s, 
PhCH2O); 1.33, 1.25, 1.22 (3s, 4 Me2C). 13C-NMR (50 MHz, (D6)DMSO): 175.6 (s, COOH); 
174.8, 173.5, 173.1 (3s, 3 CO(amide)); 155.7 (s, CO(urethane)); 137.1 (s, arom. C); 128.3, 
127.7, 127.3 (3d, 5 arom. CH); 65.5 (t, PhCH2O); 56.01, 56.0, 55.5, 54.6 (4s, 4 Me2C); 24.8, 
24.6 (2q, 4 Me2C). FAB-MS: 493 (100, [M+1]+). Anal. calc. for C24H36N4O7 (492.57): C 
58.52, H 7.37, N 11.37; found: C 58.56, H 7.10, N 11.56. 
2.8. N-Benzyloxycarbonyl-2-methylalanyl-2-methylalanyl-2-methylalanyl-2-
methylalanyl-2-methyalanine-N-methyl-N-phenylamide (Z-(Aib)5-N(Me)Ph, 12). At ca. 70°, 
11 (6.50 g, 13.2 mmol) was dissolved in DMF (30 ml). After cooling to 0°, according to GP 
1, 1a (2.60 g, 13.7 mmol) was added and the mixture stirred at r.t. overnight. The formed 
solid was filtered and dried in h.v. Yield of 12: 8.02 g (91%). Colorless solid. M.p. 235 – 
236°. IR (KBr): 3420w, 3300s, 3250m, 3040w, 2990w, 2940w, 1695m, 1675s, 1650s, 1595w, 
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1555s, 1530s, 1495m, 1465m, 1455m, 1395m, 1385m, 1365m, 1270m, 1225w, 1215w, 1170w, 
1090m, 1080m, 770w, 755w, 710m. 1H-NMR (400 MHz, (D6)DMSO, 100°): 7.75, 7.55, 7.42 
(3 br. s, 3 NH); 7.38 – 7.16 (m, 10 arom. H, 2 NH); 5.09 (s, PhCH2O); 3.31 (s, MeN); 1.45, 
1.42, 1.39, 1.37, 1.34, 1.32, 1.30 (7s, 5 Me2C). 13C-NMR (50 MHz, (D6)DMSO, 100°): 174.4, 
174.1, 173.3, 172.8, 172.2 (5s, 5 CO(amide)); 155.3 (s, CO(urethane)); 145.9, 136.5 (2s, 2 
arom. C); 127.9, 127.7, 127.2, 126.8, 126.3, 125.2 (6d, 10 arom. CH); 65.2 (t, PhCH2O); 56.0, 
55.81, 55.80, 55.7, 55.6 (5s, 5 Me2C); 39.1 (q, MeN); 25.2, 24.8, 24.2, 24.0 (4q, 5 Me2C). 
FAB-MS: 560 (20, [M+1–Ph(Me)NH]+). Anal. calc. for C35H50N6O7 (666.82): C 63.04, H 
7.56, N 12.60; found: C 63.08, H 7.48, N 12.44. 
Suitable crystals for the X-ray crystal-structure determination were grown from 
DMSO by slow evaporation of the solvent. 
2.9. N-Benzyloxycarbonyl-2-methylalanyl-2-methylalanyl-2-methylalanlyl-2-
methylalanyl-2-methyalanine (Z-(Aib)5-OH, 13). According to GP 2, a suspension of 12 (200 
mg, 0.3 mmol) in THF/6N HCl (3 ml) was stirred at ca. 60° for 1.5 h. After usual workup, the 
product was dried in h.v. Yield of 13: 169 mg (98%). Colorless solid. M.p. 234 – 235°. IR 
(KBr): 3300m, 3080w, 3030w, 299w, 2940w, 1730m, 1710m, 1660s, 1530s, 1455w, 1385w, 
1365w, 1300w, 1260m, 1230w, 1170w, 1080m, 750w, 700w. 1H-NMR (200 MHz, 
(D6)DMSO, 50°): 11.83 (br. s, COOH); 8.24, 7.85, 7.48 (3s, 3 NH); 7.34 – 7.30 (m, 5 arom. 
H, NH); 7.29 (br. s, NH); 5.10 (s, PhCH2O); 1.33, 1.27, 1.22 (3s, 5 Me2C). 13C-NMR (50 
MHz, (D6)DMSO, 80°): 174.8, 174.4, 174.0, 173.1, 173.0 (5s, COOH, 4 CO(amide)); 155.4 
(s, CO(urethane)); 136.7 (s, arom. C); 127.8, 127.3, 126.9 (3d, 5 arom. CH); 65.3 (t, 
PhCH2O); 55.8, 55.60, 55.59, 55.5, 54.5 (5s, 5 Me2C); 24.6, 24.3, 24.25, 24.1 (4q, 5 Me2C). 
Anal. calc. for C28H43N5O8 (577.68): C 58.12, H 7.50, N 12.12; found: C 58.35, H 7.57, N 
11.95. 
2.10. N-Benzyloxycarbonyl-2-methylalanyl-2-methylalanyl-2-methylalanyl-2-
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methylalanyl-2-methylalanlyl-2-methyalanine-N-methyl-N-phenylamide (Z-(Aib)6-N(Me)Ph, 
14). At ca. 70°, 13 (3.0 g, 5.2 mmol) was dissolved in DMF (11 ml). After cooling to 0°, 
according to GP 1, was added 1a (950 mg, 5.45 mmol) and the mixture stirred at r.t. for 20 h. 
The obtained oil was treated with Et2O, and the formed solid was dried in h.v. Yield of 14: 
3.58 g (92%). Colorless solid. M.p. 222 – 223°. IR (KBr): 3320m, 3040w, 2990w, 2940w, 
1745w, 1700m, 1670s, 1595w, 1525s, 1455w, 1385w, 1365w, 1270m, 1230w, 1170w, 1090m, 
1100w, 740w, 715w, 700w. 1H-NMR (200 MHz, (D6)DMSO + 5% H2O, 85°)4): 7.89, 7.61, 
7.50, 7.48 (4 br. s, 4 NH); 7.44 – 7.12 (m, 10 arom. H, 2 NH); 5.10 (s, PhCH2O); 3.31 (s, 
MeN); 1.45, 1.42, 1.40, 1.37, 1.36, 1.35, 1.32, 1.31, 1.28 (9s, 6 Me2C). 13C-NMR (50 MHz, 
(D6)DMSO, 70°)4): 174.9, 174.7, 174.5, 174.45, 174.1, 173.5, 173.14, 173.1, 172.3 (9s, 6 
C=O(amide)); 155.5, 155.4 (2s, C=O(urethan)); 146.0, 136.7 (2s, 2 arom. C); 128.1, 127.9, 
127.4, 127.0, 126.5, 125.4 (6d, 10 arom. CH); 65.3 (t, PhCH2O); 56.0, 55.9, 55.8, 55.7, 55.6, 
55.5 (6s, 6 Me2C); 38.8 (q, MeN); 25.3, 25.0, 24.5, 24.4, 24.3, 24.1 (6q, 6 Me2C).  Anal. calc. 
for C39H57N7O8 (751.93): C 62.30, H 7.64, N 13.04; found: C 62.08, H 7.62, N 12.82. 
Suitable crystals for the X-ray crystal-structure determination were grown from 
DMSO/H2O by slow evaporation of the solvent. 
3. Synthesis of Z-(Aib)3-L-Pro-(Aib)3-N(Me)Ph (21). 3.1. N-Benzyloxycarbonyl-2-
methylalanyl-2-methyalanine-N,N-dimethylamide (Z-(Aib)2-NMe2, 6b). According to GP 1, 
to a soln. of Z-Aib-OH (4.0 g, 16.9 mmol) in Et2O (36 ml) at 0°, azirine 1b (2.1 g, 18.6 mmol) 
was added, and the mixture was stirred at r.t. After 1 h, a precipitate formed, and after 24 h, 
the reaction was complete. The solid was filtered, washed with Et2O, and dried in h.v. Yield 
of 6b: 5.13 g (87%). Colorless solid. M.p. 159 – 161°. 1H-NMR (200 MHz, CDCl3): 7.56 (br. 
s, NH); 7.40 – 7.30 (m, 5 arom. H); 5.44 (br. s, NH urethane); 5.09 (s, PhCH2O); 3.03 (s, 
Me2N); 1.58, 1.53 (2s, 2 Me2C). CI-MS: 350 (45, [M+1]+), 305 (100). 
                                                 
4) Some of the signals were doubled, most likely because of the presence of conformers. 
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3.2. N-Benzyloxycarbonyl-2-methylalanyl-2-methylalanyl-2-methyalanine-N,N-
dimethylamide (Z-(Aib)3-NMe2, 8b). According to GP 2, 6b (5.0 g, 14.0 mmol) was 
hydrolyzed to give 7 (4.40 g, 13.65 mmol; see section 2.3). The crude material was dissolved 
in a mixture of Et2O (28 ml) and THF (10 ml), and azirine 1b (1.77 g, 15.7 mmol) was added. 
After 42 h, the precipitate was filtered, the product washed with Et2O, and dried in h.v. Yield 
of 8b: 5.46 g (92%). Colorless solid. M.p. 185 – 186°. 1H-NMR (200 MHz, CDCl3): 7.43 (br. 
s, NH); 7.36 – 7.32 (m, 5 arom. H, NH); 6.72 (br. s, NH); 5.13 (s, PhCH2O); 2.97 (br. s, 
Me2N); 1.43, 1.42, 1.38 (3s, 3 Me2C). CI-MS: 435 (17, [M+1]+), 390 (100). 
3.3. N-Benzyloxycarbonyl-2-methylalanyl-2-methylalanyl-2-methyalanine (Z-(Aib)3-
OH, 9). The hydrolysis of 8b (5.32 g, 12.2 mmol) according to GP 2 gave 9 (4.10 g, 96%; see 
section 2.5).  
3.4. N-Benzyloxycarbonyl-L-prolyl-2-methyalanine-N-methyl-N-phenylamide (Z-Pro-
Aib-N(Me)Ph, 15). According to GP 1, to a soln. of Z-Pro-OH (5.0 g, 20.06 mmol) in abs. 
THF (50 ml) at 0°, azirine 1a (3.7 g, 21.06 mmol) was added and the mixture was stirred 
under Ar at r.t. for 5 d. The solvent was evaporated and the residue was crystallized by 
treatment with Et2O and hexane. The product was washed with Et2O and dried in h.v. Yield of 
15: 7.90 g (93%). Colorless solid. M.p. 119 – 120°. [α]D20 = – 51.0 (EtOH, c = 0.97). IR 
(KBr): 3420w, 3280m, 3040w. 3000w, 2970w, 2880w, 1710s, 1675s, 1625s, 1590m, 1535m, 
1495m, 1470w, 1455w, 1420s, 1390m, 1375w, 1355m, 1250m, 1215w, 1170w, 1120m, 
1090m, 1070w, 1030w, 1020w, 995w, 960w, 915w, 870w, 775w, 710m, 700w. 1H-NMR (200 
MHz, (D6)DMSO): 8.12 (br. s, NH); 7.40 – 7.10 (m, 10 arom. H); 5.20 – 4.85 (m, PhCH2O); 
4.30 – 4.10 (m, CH(2) Pro); 3.45 – 3.30 (m, CH2(5) Pro); 3.32 (s, MeN); 2.30 – 1.70 (m, 
CH2(3), CH2(4) Pro); 1.35, 1.31 (2s, Me2C). CI-MS:  424 (43, [M+1]+), 317 (100). Anal. calc. 
for C24H29N3O4 (423.52): C 68.00, H 6.90, N 9.92; found: C 67.33, H 6.89, N 10.03. 
3.5. N-Benzyloxycarbonyl-L-prolyl-2-methyalanine (Z-Pro-Aib-OH, 16). The 
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hydrolysis of 15 (6.63 g, 15.65 mmol) according to GP 2 for 2.75 h gave 16 (4.19 g, 80%) as 
a colorless foam. 1H-NMR (90 MHz, CDCl3): 9.30 (br. s, COOH); 7.50 – 7.10 (m, 5 arom. H, 
NH); 5.10 (br. s, PhCH2O); 4.50 – 4.10 (m, CH(2) Pro); 3.85 – 3.30 (m, CH2(5) Pro); 2.30 – 
1.80 (m, CH2(3), CH2(4) Pro); 1.50 (br. s, Me2C). 
3.6. N-Benzyloxycarbonyl-L-prolyl-2-methylalanyl-2-methyalanine-N-methyl-N-
phenylamide (Z-Pro-(Aib)2-N(Me)Ph, 17). According to GP 1, to a soln. of 16 (4.20 g, 12.56 
mmol) in Et2O (130 ml) at 0°, 1a (2.53 g, 14.45 mmol) was added and the mixture was stirred 
under Ar at 0° overnight. The precipitate was filtered, washed with Et2O, and dried in h.v. 
Yield of 17: 5.69 g (89%). Colorless solid. M.p. 147 – 148°. [α]D22 = – 23.1 (EtOH, c = 
0.943). IR (KBr): 3400m, 3310m, 2990w, 2940w, 2870w, 1695s, 1685s, 1625s, 1595w, 
1530w, 1495w, 1440w, 1425m, 1395w, 1365w, 1335m, 1280w, 1240w, 1225w, 1205w, 
1110w, 1090w, 1000w, 995w, 980w, 770w, 730w, 705w. 1H-NMR (400 MHz, (D6)DMSO): 
8.17, 7.86 (2s, 2 NH); 7.50 – 7.10 (m, 10 arom. H); 5.09 (s, PhCH2O); 4.20 – 4.10 (m, CH(2) 
Pro); 3.60 – 3.30 (m, CH2(5) Pro); 3.32 (s, MeN); 2.20 – 1.70 (m, CH2(3), CH2(4) Pro); 1.36, 
1.35, 1.29, 1.27 (4s, 2 Me2C). CI-MS:  509 (2, [M+1]+), 402 (100). Anal. calc. for C28H36N4O5 
(508.62): C 66.12, H 7.13, N 11.02; found: C 65.89, H 7.22, N 11.19. 
3.7. N-Benzyloxycarbonyl-L-prolyl-2methylalanyl-2-methyalanine (Z-Pro-(Aib)2-OH, 
18). The hydrolysis of 17 (5.45 g, 10.72 mmol) according to GP 2 for 3.5 h gave 18 (4.49 g, 
94%) as a colorless foam. [α]D22 = – 36.0 (EtOH, c = 1.197). IR (KBr): 3330m, 3300m, 
3030w, 2990w, 2980w, 2940w, 2880w, 1730m, 1685s, 1650s, 1530m, 1500w, 1470m, 1440m, 
1395w, 1385w, 1360m, 1315w, 1280w, 1260w, 1240w, 1170m, 1130w, 1090w, 1040w, 990w, 
975w, 770w, 750w, 700w.  1H-NMR (400 MHz, (D6)DMSO): 8.21 (s, NH); 7.50 – 7.20 (m, 5 
arom. H); 7.18 (s, NH); 5.07 (s, PhCH2O); 4.20 – 4.10 (m, CH(2) Pro); 3.50 – 3.20 (m, 
CH2(5) Pro); 2.20 – 1.70 (m, CH2(3), CH2(4) Pro); 1.33, 1.32, 1.31, 1.29 (4s, 2 Me2C). CI-
MS: 420 (100, [M+1]+). Anal. calc. for C21H29N3O6 (419.48): C 60.13, H 6.97, N 10.02; 
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found: C 59.79, H 6.84, N 9.80. 
3.8. N-Benzyloxycarbonyl-L-prolyl-2-methylalanyl-2-methylalanyl-2-methyalanine-N-
methyl-N-phenylamide (Z-Pro-(Aib)3-N(Me)Ph, 19). According to GP 1, to a soln. of 18 (4.0 
g, 9.54 mmol) in a mixture of abs. THF (19 ml) and abs. DMF (10 ml) at 0°, 1a (1.94 g, 11.15 
mmol) was added slowly and the mixture was stirred under Ar at r.t. for 45 h. The precipitate 
was filtered, washed with Et2O, and dried in h.v. Yield of 19: 4.64 g (82%). Colorless solid. 
[α]D22 = – 46.0 (EtOH, c = 1.062). IR (KBr): 3400w, 3300w, 3070w, 3040w, 2990w, 2950w, 
2880w, 1670s (br), 1640s (br), 1595w, 1535s, 1495s, 1470w, 1455s, 1425s, 1395s, 1365s, 
1340w, 1290w, 1275w, 1245w, 1215w, 1170w, 1125m, 1100m, 1025w, 985w, 935w, 775w, 
740w, 715m, 700w. 1H-NMR (400 MHz, (D6)DMSO): 8.68, 7.43 (2s, 2 NH); 7.40 – 7.10 (m, 
10 arom. H); 7.02 (s, NH); 5.12, 4.98 (AB, JAB = 12.8, PhCH2O); 4.25 – 4.15 (m, CH(2) Pro); 
3.55 – 3.35 (m, CH2(5) Pro); 3.30 (s, MeN); 2.20 – 1.75 (m, CH2(3), CH2(4) Pro); 1.36, 1.34 
(2s, 3 Me2C). 13C-NMR (50 MHz, CD3OD): 177.0, 176.1, 176.0, 175.4 (4s, 4 C=O(amide)); 
157.0 (s, C=O(urethane)); 147.4, 138.2 (2s, 2 arom. C); 130.5, 129.9, 129.5, 129.0, 128.5, 
128.3 (6d, 10 arom. CH); 68.6 (t, PhCH2O); 62.2 (d, C(2) Pro); 58.7, 58.4, 58.1 (3s, 3 Me2C); 
48.2 (t, CH2(5) Pro); 41.3 (q, MeN); 31.4, 26.0 (2t, CH2(3), CH2(4) Pro); 27.5, 26.8, 26.7, 
26.3, 24.9, 24.4 (6q, 3 Me2C). CI-MS: 487 (96, [M+1–Ph(Me)NH]+), 108 (100). Anal. calc. 
for C32H43N5O6 (593.73): C 64.74, H 7.30, N 11.80; found: C 64.53, H 7.20, N 12.01. 
3.9. L-Prolyl-2-methylalanyl-2-methylalanyl-2-methyalanine-N-methyl-N-
phenylamide (H-Pro-(Aib)3-N(Me)Ph, 20). To a stirred soln. of 19 (500 mg, 0.84 mmol) in 
MeOH (5.5 ml) was added in small portions Pd/C 10% (50 mg) at r.t., and a stream of H2 was 
bubbled through the mixture for 2 h. Then, the mixture was filtered through Celite, the filtrate 
evaporated, the residue crystallized by treatment with Et2O, and dried in h.v. Yield of 20: 345 
mg (89%). Colorless solid. [α]D22 = – 24.3 (EtOH, c = 0.420). IR (KBr): 3440m (br), 3300m 
(br), 2980w, 2930w, 1660s (br), 1595w, 1530m (br), 1495m, 1460w, 1390w, 1365w, 1280w, 
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1225w, 1170w, 1095w, 770w, 710w. 1H-NMR (400 MHz, CDCl3): 8.02, 7.05 (2s, 2 NH); 7.40 
– 7.20 (m, 5 arom. H, NH); 6.83 (br. s, NH); 3.96 (dd, J = 9.1, 5.3, CH(2) Pro); 3.31 (s, MeN); 
3.10 – 2.85 (m, CH2(5) Pro); 2.20 – 1.65 (m, CH2(3), CH2(4) Pro); 1.49, 1.48, 1.47 (3s, 3 
Me2C). 13C-NMR (50 MHz, CDCl3): 175.8, 173.7, 173.2, 173.0 (4s, 4 C=O(amide)); 145.2 (s, 
C arom.); 129.1, 127.9, 127.2 (3d, 5 arom. CH); 60.7 (d, C(2) Pro); 57.9, 57.1, 56.7 (3s, 3 
Me2C); 47.2 (t, CH2(5) Pro); 40.8 (q, MeN); 30.6, 26.2 (2t, CH2(3), CH2(4) Pro); 25.7, 25.5, 
25.4, 25.0, 24.9 (5q, 3 Me2C). FAB-MS: 460 (20, [M+1]+), 353 (92).  
3.10. N-Benzyloxycarbonyl-2-methylalanyl-2-methylalanyl-2-methylalanyl-L-prolyl-2-
methylalanyl-2-methylalanyl-2-methyalanine-N-methyl-N-phenylamide (Z-(Aib)3-Pro-(Aib)3-
N(Me)Ph, 21). To a stirred soln. of 9 (80.6 mg, 0.20 mmol) in DMF (1 ml) at 0°, dicyclohexyl 
carbodiimide (CCD, 41 mg, 0.20 mmol) was added. After 3 min, ZnCl2 (55 mg, 0.40 mol) 
and then 20 (100 mg, 0.22 mmol) were added in small portions, and the mixture was stirred 
under Ar at r.t. for 40 h. Then, aq. Na2CO3 soln. (2.5%) was added and the mixture was 
extracted with CH2Cl2 (3×). The combined org. phase was washed with 2N HCl (3×). The org. 
phase was dried (Na2SO4), the solvent evaporated, and the residue dried in h.v. Yield of 21: 
125 mg (75%). Colorless solid. 1H-NMR (400 MHz, CDCl3): 7.77, 7.45, 7.40, 7.23, 6.35, 
5.82 (6s, 6 NH); 7.50 – 7.10 (m, 10 arom. H); 5.19, 5.08 (AB, JAB = 12.6, PhCH2O); 4.22 (t, J 
= 8.1, CH(2) Pro); 3.75 – 3.55 (m, CH2(5) Pro); 3.45 (s, MeN); 2.40 – 2.25, 2.10 – 1.70 (2m, 
CH2(3), CH2(4) Pro); 1.61, 1.59, 1.55, 1.51, 1.49, 1.46, 1.45, 1.42, 1.41, 1.34, 1.27, 1.26 (12s, 
6 Me2C). 13C-NMR (50 MHz, CDCl3): 174.9, 174.8, 174.5, 174.1, 173.6, 173.2, 173.1 (7s, 7 
C=O(amide)); 156.2 (s, C=O(urethane)); 146.2, 136.7 (2s, 2 arom. C); 128.9, 128.6, 128.1, 
127.2, 127.1, 126.3 (6d, 10 arom. CH); 66.5 (t, PhCH2O); 64.0 (d, C(2) Pro); 57.1, 57.0, 56.8, 
56.6 (4s, 6 Me2C); 48.4 (t, CH2(5) Pro); 40.1 (q, MeN); 28.8, 26.2 (2t, CH2(3), CH2(4) Pro); 
27.8, 27.1, 26.7, 26.1, 25.8, 25.7, 25.5, 24.2, 23.9, 23.4, 23.2 (11q, 6 Me2C). FAB-MS: 871 
(15, [M+Na]+), 742 (100, [M+1–Ph(Me)NH), 390 (100), 305 (100). 
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4. X-Ray Crystal-Structure Determination of 6a, 8a, 10, 12, and 14 (Table 3 and Figs. 
1 – 3)5). All measurements were performed on a Nicolet R3 diffractometer using graphite-
monochromated MoKα radiation (λ 0.71073 Å). The data collection and refinement 
parameters are given in Table 3, and views of the molecules are shown in Figs. 1 – 3. The 
intensities were corrected for Lorentz and polarization effects, but not for absorption. The 
structures were solved by direct methods using SHELXS86 [23], which revealed the positions 
of all non-H-atoms. In the case of 8a, there are two symmetry-independent molecules in the 
asymmetric unit. The atomic coordinates of the two molecules were tested carefully for a 
relationship from a higher symmetry space group using the program PLATON [24], but none 
could be found. In the case of 10, the asymmetric unit contains one molecule of the peptide 
plus one molecule of H2O. In the case of 14, one significant electron density peak (ca. 0.5 
e/Å3) remained after all other atoms were accounted for. This peak was assigned as a partially 
occupied site for a H2O molecule [O(9)], with a site occupation factor of 0.25. The non-H-
atoms were refined anisotropically. The amide H-atoms were placed in the positions indicated 
by a difference electron density map and their positions were allowed to refine together with 
individual isotropic displacement parameters. The H-atoms of the H2O molecule in 14 could 
not be located. Bond lengths restraints were applied to the N(5)–H and N(6)–H bonds in 
compound 12. All remaining H-atoms were fixed in geometrically calculated positions and 
refined by using a rigid model where each H-atom was assigned a fixed isotropic 
displacement parameter with a value equal to 1.2Ueq of its parent C-atom (1.5Ueq for Me 
groups).  The refinements of the structures were carried out on F2 by using full-matrix least-
squares procedures, which minimized the function Σw(Fo2– Fc2)2. A correction for secondary 
                                                 
5) CCDC-817459–817463 contains the supplementary crystallographic data for this paper. 
These data can be obtained free of charge from the Cambridge Crystallographic Data 
Centre via http://www.ccdc.cam.ac.uk/data_request/cif. 
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extinction was applied in the cases of 6a, 8a, and 10. Neutral atom scattering factors for non-
H-atoms were taken from [25a], and the scattering factors for H-atoms were taken from [26]. 
Anomalous dispersion effects were included in Fc [27]; the values for f ' and f " were those of 
[25b]. The values of the mass attenuation coefficients are those of [25c]. All calculations were 
performed using the SHELXL97 [28] program. 
 
Table 3. Crystallographic Data for Compounds 6a, 8a, 10, 12, and 14 
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Legends 
 
Fig. 1. ORTEP Plots [20] of the molecular structures of a) 6a and b) one of the two 
symmetry-independent molecules of 8a (50% probability ellipsoids, arbitrary numbering of the 
atoms) 
Fig. 2. ORTEP Plots [20] of the molecular structures of a) 10 and b) 12 (50% 
probability ellipsoids, arbitrary numbering of the atoms) 
 
Fig. 3. ORTEP Plot [20] of the molecular structure of 14 (50% probability ellipsoids, 
arbitrary numbering of the atoms) 
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Table 1. Torsion Angles ω, φ, and ψ of the Backbone of Compounds 6a, 8a, 10, 12, 
and 14 in the Crystal (atom numbering refers to Figs. 1 – 3) 
 
Compound Amino Acid  Atoms Torsion Angles (°) 
6a Aib(1) φ1 C(5)–N(3)–C(4)–C(3) –62.9(3) 
  ψ1 N(3)–C(4)–C(3)–N(2) 165.6(2) 
  ω1 C(4)–C(3)–N(2)–C(2) 171.1(2) 
 Aib(2) φ2 C(3)–N(2)–C(2)–C(1) 55.2(3) 
  ψ2 N(2)–C(2)–C(1)–N(1) 41.9(3) 
  ω2 C(2)–C(1)–N(1)–C(12) 179.0(2) 
8aa) Aib(1) φ1 C(7)–N(4)–C(6)–C(5) 52.5(3); –52.1(3) 
  ψ1 N(4)–C(6)–C(5)–N(3) 37.3(2); –37.3(3) 
  ω1 C(6)–C(5)–N(3)–C(4) 174.4(2); –172.9(2) 
 Aib(2) φ2 C(5)–N(3)–C(4)–C(3) 61.7(3); –60.4(3) 
  ψ2 N(3)–C(4)–C(3)–N(2) 29.7(3); –30.8(3) 
  ω2 C(4)–C(3)–N(2)–C(2) 164.5(2); –163.9(2) 
 Aib(3) φ3 C(3)–N(2)–C(2)–C(1) 58.0(3); –59.0(3) 
  ψ3 N(2)–C(2)–C(1)–N(1) 58.5(3); –56.7(3) 
  ω3 C(2)–C(1)–N(1)–C(16) 161.7(2); –165.4(2) 
10 Aib(1) φ1 C(9)–N(5)–C(8)–C(7) –54.8(3) 
  ψ1 N(5)–C(8)–C(7)–N(4) –29.4(3) 
  ω1 C(8)–C(7)–N(4)–C(6) –179.9(2) 
 Aib(2) φ2 C(7)–N(4)–C(6)–C(5) –54.8(3) 
  ψ2 N(4)–C(6)–C(5)–N(3) –28.4(4) 
  ω2 C(6)–C(5)–N(3)–C(4) 179.6(2) 
 Aib(3) φ3 C(5)–N(3)–C(4)–C(3) –56.6(4) 
  ψ3 N(3)–C(4)–C(3)–N(2) –29.2(4) 
  ω3 C(4)–C(3)–N(2)–C(2) 174.7(3) 
 Aib(4) φ4 C(3)–N(2)–C(2)–C(1) 54.6(4) 
  ψ4 N(2)–C(2)–C(1)–N(1) 53.4(4) 
  ω4 C(2)–C(1)–N(1)–C(20) 168.7(3) 
                          
 
a) Two symmetry-independent molecules  
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Table 1. Torsion Angles ω, φ, and ψ of the Backbone of Compounds 6a, 8a, 10, 12, 
and 14 in the Crystal (atom numbering refers to Figs. 1 – 3) (continued) 
Compound Amino Acid  Atoms Torsion Angles (°) 
12 Aib(1) φ1 C(11)–N(6)–C(10)–C(9) 55.3(6) 
  ψ1 N(6)–C(10)–C(9)–N(5) 32.5(6) 
  ω1 C(10)–C(9)–N(5)–C(8) 174.8(4) 
 Aib(2) φ2 C(9)–N(5)–C(8)–C(7) 55.2(6) 
  ψ2 N(5)–C(8)–C(7)–N(4) 28.9(6) 
  ω2 C(8)–C(7)–N(4)–C(6) –179.3(5) 
 Aib(3) φ3 C(7)–N(4)–C(6)–C(5) 54.2(7) 
  ψ3 N(4)–C(6)–C(5)–N(3) 25.9(7) 
  ω3 C(6)–C(5)–N(3)–C(4) 178.1(4) 
 Aib(4) φ4 C(5)–N(3)–C(4)–C(3) 60.4(7) 
  ψ4 N(3)–C(4)–C(3)–N(2) 26.5(7) 
  ω4 C(4)–C(3)–N(2)–C(2) –172.1(5) 
 Aib(5) φ5 C(3)–N(2)–C(2)–C(1) –47.6(6) 
  ψ5 N(2)–C(2)–C(1)–N(1) –54.1(5) 
  ω5 C(2)–C(1)–N(1)–C(24) 178.3(4) 
14 Aib(1) φ1 C(13)–N(7)–C(12)–C(11) –50.8(6) 
  ψ1 N(7)–C(12)–C(11)–N(6) –35.8(5) 
  ω1 C(12)–C(11)–N(6)–C(10) –178.2(3) 
 Aib(2) φ2 C(11)–N(6)–C(10)–C(9) –50.4(5) 
  ψ2 N(6)–C(10)–C(9)–N(5) –39.6(5) 
  ω2 C(10)–C(9)–N(5)–C(8) –172.0(3) 
 Aib(3) φ3 C(9)–N(5)–C(8)–C(7) –57.8(4) 
  ψ3 N(5)–C(8)–C(7)–N(4) –31.4(4) 
  ω3 C(8)–C(7)–N(4)–C(6) –175.8(3) 
 Aib(4) φ4 C(7)–N(4)–C(6)–C(5) –55.5(4) 
  ψ4 N(4)–C(6)–C(5)–N(3) –33.6(4) 
  ω4 C(6)–C(5)–N(3)–C(4) –176.5(3) 
 Aib(5) φ5 C(5)–N(3)–C(4)–C(3) –58.3(4) 
  ψ5 N(3)–C(4)–C(3)–N(2) –35.0(4) 
  ω5 C(4)–C(3)–N(2)–C(2) 174.1(3) 
 Aib(6) φ6 C(3)–N(2)–C(2)–C(1) 49.3(4) 
  ψ6 N(2)–C(2)–C(1)–N(1) 52.7(4) 
  ω6 C(2)–C(1)–N(1)–C(28) –179.4(3) 
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Table 2.  Intramolecular H-Bonds of Compounds 8a, 10, 12, and 14 (atom numbering refers 
to Figs. 1 – 3) 
Compound H-Bond N–H (Å) H……O (Å) N……O (Å) N–H……O (°) 
8a (A) N(2)–H……O(4) 0.79(2) 2.26(2) 3.027(3) 162(2) 
8a (B) N(32)–H……O(34) 0.83(2) 2.28(2) 3.070(3) 160(2) 
10 N(2)–H……O(4) 0.85(3) 2.11(3) 2.950(3) 166(2) 
 N(3)–H……O(5) 0.88(3) 2.13(3) 3.001(4) 168(2) 
12 N(2)–H……O(4) 0.83(4) 2.25(5) 3.077(5) 171(4) 
 N(3)–H……O(5) 0.87(5) 2.04(5) 2.906(6) 172(4) 
 N(4)–H……O(6) 0.91(4) 2.19(5) 3.087(6) 168(4) 
14 N(2)–H……O(4) 0.86(3) 2.22(4) 3.031(4) 156(3) 
 N(3)–H……O(5) 0.87(4) 2.30(4) 3.133(4) 160(3) 
 N(4)–H……O(6) 0.88(4) 2.27(4) 3.094(4) 156(3) 
 N(5)–H……O(7) 0.81(4) 2.22(4) 3.012(4) 167(4) 
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Table 3.  Crystallographic Data for Compounds 6a, 8a, 10, 12, and 14 
____________________________________________________________________________________ 
  
 6a 8a 10 
____________________________________________________________________________________ 
 
Crystallized from DMSO/H2O DMSO/H2O DMSO/H2O 
Empirical formula C23H29N3O4 C27H36N4O5 C31H43N5O6.H2O 
Formula weight 411.50 496.60 599.72 
Crystal color, habit colorless, prism colorless, prism colorless, prism 
Temperature [K] 294(1) 294(1) 294(1) 
Crystal system monoclinic triclinic triclinic 
Space group P21/n P
_
,1 P  
_
,1
Z 4 4 2 
Reflections for cell determination 25 25 25 
2θ range for cell determination [°] 20 – 28 20 – 28 24 – 28 
Unit cell parameters a [Å] 13.875(3) 13.171(1) 8.660(4) 
 b [Å] 10.796(4) 14.694(3) 11.731(5) 
 c [Å] 15.499(4) 15.546(3) 16.839(7) 
 α [°] 90 99.42(1) 103.25(3) 
 β [°] 103.27(2) 109.99(1) 96.22(3) 
 γ [°] 90 91.07(1) 90.81(3) 
 V [Å3] 2259(1) 2780.2(8) 1653(1) 
Dx [g cm–1] 1.211 1.186 1.204 
µ(MoKα) [mm–1] 0.0835 0.0825 0.0858 
Scan type ω ω ω 
2θ(max) [°] 46 46 46 
Total reflections measured 3952 8238 5013 
Symmetry independent reflections 2833 7745 4601 
Reflections with I > 2σ(I) 2080 5540 3184 
Reflections used 2833 7745 4601 
Parameters refined; restraints 285; 0 688; 0 426; 0 
Final  R(F) [I > 2σ(I)] 0.0431  0.0431 0.0514 
 wR(F2) (all data) 0.1092 0.1069 0.1465 
Weights: a and ba) 0.0543; 0.4155 0.0503; 0.3506 0.0776; 0.2280 
Goodness of fit 1.022 1.027 1.029 
Secondary extinction coefficient 0.008(1) 0.0046(5) 0.008(2) 
Final ∆max/σ 0.001 0.001 0.001 
∆ρ (max; min) [e Å
–3
] 0.12; –0.13 0.20; –0.14 0.22; –0.18 
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a) w = [σ2 (Fo2) + (aP)2 + bP]–1 where P = (Fo2 + 2Fc2)/3 
 
Table 3.  Crystallographic Data for Compounds 6a, 8a, 10, 12, and 14 (continued) 
____________________________________________________________________________________ 
  
 12 14  
____________________________________________________________________________________ 
 
Crystallized from DMSO DMSO/H2O  
Empirical formula C35H50N6O7 C39H57N7O8.0.25 H2O  
Formula weight 666.82 756.43  
Crystal color, habit colorless, prism colorless, prism  
Temperature [K] 294(1) 294(1)  
Crystal system monoclinic monoclinic  
Space group P21/c P21  
Z 4 2  
Reflections for cell determination 25 25  
2θ range for cell determination [°] 20 – 24 20 – 26  
Unit cell parameters a [Å] 11.585(4) 9.092(2)  
 b [Å] 18.943(5) 16.052(4)  
 c [Å] 17.718(7) 14.968(4)  
 α [°] 90 90  
 β [°] 103.67(2) 100.93(2)  
 γ [°] 90 90  
 V [Å3] 3778(2) 2144.9(9)  
Dx [g cm–1] 1.172 1.171  
µ(MoKα) [mm–1] 0.0824 0.0829  
Scan type ω ω  
2θ(max) [°] 46 52  
Total reflections measured 5831 4749  
Symmetry independent reflections 5258 4378  
Reflections with I > 2σ(I) 2454 3232  
Reflections used 5258 4378  
Parameters refined; restraints 464; 2 534; 1  
Final  R(F) [I > 2σ(I)] 0.0734  0.0443  
 wR(F2) (all data) 0.1883 0.1137  
Weights: a and ba) 0.0845; 0 0.0620; 0.1035  
Goodness of fit 0.943 1.020  
Secondary extinction coefficient - -  
Final ∆max/σ 0.002 0.001  
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∆ρ (max; min) [e Å
–3
] 0.27; –0.19 0.13; –0.12  
 
 
a) w = [σ2 (Fo2) + (aP)2 + bP]–1 where P = (Fo2 + 2Fc2)/3 
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Scheme 3 
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Figure 1a (6a) 
 
 
Figure 1b (8a) 
 
Figure 2a (10) 
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Figure 2b (12) 
 
 
Figure 3 (14) 
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